Literature DB >> 21626672

Fanconi anemia-like presentation in an infant with constitutional deletion of 21q including the RUNX1 gene.

Eleanor S Click1, Barbara Cox, Susan B Olson, Markus Grompe, Yassmine Akkari, Lisa A Moreau, Akiko Shimamura, Darci L Sternen, Yajuan J Liu, Kathleen A Leppig, Dana C Matthews, Melissa A Parisi.   

Abstract

We describe a newborn female with a de novo interstitial deletion of chromosome 21q21.1-22.12 including the RUNX1 gene who had developmental delay, multiple congenital anomalies, tetralogy of Fallot, anemia, and chronic thromobocytopenia requiring frequent platelet transfusions from birth. Because of her physical and hematologic abnormalities, she was tested for Fanconi anemia (FA). Lymphocytes and fibroblasts from this patient demonstrated increased chromosome breakage with exposure to the clastogen mitomycin C, but not, in contrast to most FA patients, to diepoxybutane. Further testing by Western analysis and complementation testing did not show a defect in the function of known Fanconi proteins. Her constitutional deletion was later found to span 13.2 Mb by chromosome microarray analysis, encompassing the RUNX1 gene that has been implicated in thrombocytopenia and predisposition to acute myelogenous leukemia (AML) when in the haploinsufficient state. We compare her phenotype to other individuals with similar 21q deletions and thrombocytopenia, as well as those with FA. We suggest that deletion of RUNX1 or another critical gene within the deleted region may result in chromosomal instability similar to that seen in FA.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626672     DOI: 10.1002/ajmg.a.34024

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Combined immunodeficiency in a patient with mosaic monosomy 21.

Authors:  Erez Rechavi; Sarina Levy-Mendelovich; Tali Stauber; Jana Shamash; Shlomit Reinstein; Helly Vernitsky; Dganit Adam; Amos J Simon; Atar Lev; Annick Raas-Rothschild; Raz Somech
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

2.  Deletion of the App-Runx1 region in mice models human partial monosomy 21.

Authors:  Thomas Arbogast; Matthieu Raveau; Claire Chevalier; Valérie Nalesso; Doulaye Dembele; Hugues Jacobs; Olivia Wendling; Michel Roux; Arnaud Duchon; Yann Herault
Journal:  Dis Model Mech       Date:  2015-04-16       Impact factor: 5.758

3.  Genome-Wide DNA Methylation Analysis and Epigenetic Variations Associated with Congenital Aortic Valve Stenosis (AVS).

Authors:  Uppala Radhakrishna; Samet Albayrak; Zeynep Alpay-Savasan; Amna Zeb; Onur Turkoglu; Paul Sobolewski; Ray O Bahado-Singh
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

4.  Proximal 21q deletion as a result of a de novo unbalanced t(12;21) translocation in a patient with dysmorphic features, hepatomegaly, thick myocardium and delayed psychomotor development.

Authors:  Cathrine Jespersgaard; Ida N Damgaard; Nanna Cornelius; Iben Bache; Niels Knabe; Maria J Miranda; Zeynep Tümer
Journal:  Mol Cytogenet       Date:  2016-02-04       Impact factor: 2.009

Review 5.  The role of DNA methylation in syndromic and non-syndromic congenital heart disease.

Authors:  Jiali Cao; Qichang Wu; Yanru Huang; Lingye Wang; Zhiying Su; Huiming Ye
Journal:  Clin Epigenetics       Date:  2021-04-26       Impact factor: 6.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.